MAAT INDEX

CLAIM #42900 · Altria Group (MO) · 2023Q2 earnings call · Aug 1, 2023 · due Dec 31, 2023

From a standpoint of the age restriction I think you were referring to, you know we just recently closed it and we're assessing the timing of following that. You know we would have a target in mind by the end of this year.

Billy Gifford · CEO

PENDING
graded after results covering Dec 31, 2023 are reported

In context

f consumers and so we certainly see that as an opportunity. And you heard in the remarks, you know the NJOY ACE is the only pod that has received FDA authorization. When you think about the disposable side, the growth, at least what we're seeing in the marketplace is with the factor of flavors that are illicitly in the marketplace. So as the FDA certainly steps up enforcement and we see enforcement take place and those illicit products come out of the marketplace, we see the potential again, because NJOY was able to receive authorization for their disposable, the opportunity for growth in that space. But we feel like the appropriate focus is on that large pod base, consumer base, until the illicit plethora of flavors and the flavors that are illicitly in the marketplace are cleaned up. From a standpoint of the age restriction I think you were referring to, you know we just recently closed it and we're excited about that technology. We're assessing the timing of following that. You know we would have a target in mind by the end of this year. But I think what's so exciting about it is it's the regulatory team that we certainly welcome onboard from the NJOY that was – that successfully navigated it. It’s the only pod based product that has navigated the regulatory. So we're excited. They had started the application and again, we would target following that by the end of the year. Gaurav Jain: Sure. Thank you. And can you also update us on this Juul patent litigation that they have filed against NJOY, which I found very surprising, considering I thought you would have – when you walked away from June, you would have gained access to all their IP. So could you just help us understand what's happening there? A - Billy Gifford: Sure. We believe that the litigation against us is meritless and we

Verify independently

SEC filings for MO · Claim quote is verbatim from the 2023Q2 earnings call.